|
 |
 |
SYS-CON.TV Webcasts
Comments
Did you read today's front page stories & breaking news?
SYS-CON.TV
|
Today's Top SOA Links
From the Wires
Pfenex Inc., Through Its Reagent Proteins Business Division, Announces Capacity Expansion For cGMP CRM197 Production
By: PR Newswire
Jan. 16, 2013 06:00 AM
SAN DIEGO, Jan. 16, 2013 /PRNewswire/ -- Pfenex Inc.'s Reagent Proteins division announced today that its CRM197 manufacturing partner, Serum Institute of India Ltd., has commenced the construction of a new large scale cGMP CRM197 production facility. This facility, targeted for completion in 2014, will be the largest dedicated CRM197 production facility in the world with annual capacity to produce in excess of 50 kilograms of cGMP grade CRM197. The additional capacity will enable Reagent Proteins to meet the increasing global demand for CRM197 and to continue to support conjugate vaccine products currently being developed by its partners. Serum Institute utilizes Pfenex Expression Technology™ as the production platform, enabling high titers of this high quality conjugate vaccine carrier protein. The Pfenex CRM197 currently being manufactured at Serum Institute is also being used by Serum Institute as the carrier protein for its own internal pneumococcal polysaccharide conjugate vaccine programs. Reagent Proteins offers pre-clinical and cGMP grade CRM197 carrier protein to the vaccine industry enabling novel conjugate vaccine development efforts. In addition, Reagent Proteins provides partners access to a Type 2 Biologics Master File in support of regulatory submissions for their conjugate vaccines. Currently, Pfenex CRM197 is a component in preclinical and clinical stage human vaccine products in development in both North America and Europe. "CRM197 is increasingly being used by the global vaccine development community, and this new facility allows us to not only meet the growing needs of our current partners, but also allows us to support new research and development efforts," said Dr. Bertrand Liang, CEO of Pfenex Inc. "By leveraging our long standing relationship with Serum Institute of India, we are able to further provide our partners with access to high quality vaccine components produced using the powerful Pfenex Expression Technology™, all the way from early stage research through the clinic and into commercialization." For the full press release please visit (http://www.pfenex.com/news/details/30) About Pfenex Inc. SOURCE Pfenex Inc.
Web 2.0 Latest News
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
|
SYS-CON Featured Whitepapers
Most Read This Week
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
| | | | | | | | |
|
|
|
|
|
|
| | | | | | | | | | | | | | | | | | | | | | | | | | |
|
|
| SYS-CON MEDIA: | | | | |
| SYS-CON EVENTS: | | | | | |
| INTERNATIONAL SITES: | | | | | | | | | | |
 |
Terms of Use & Our Privacy Statement  About Newsfeeds / Video Feeds |
| Copyright ©1994-2008 SYS-CON Publications, Inc. All Rights Reserved. All marks are trademarks of SYS-CON Media. |
| Reproduction in whole or in part in any form or medium without express written permission of SYS-CON Publications, Inc. is prohibited. |
.gif)
The help desk forms the backbone of IT operations for many federal, state and local government agencies. In fact, the cross-functional nature of its operation means the help desk directly impacts productivity and is an essential part of what enables an agency to meet its stakeholder ne...
With 10 simultaneous tracks, keynotes, general sessions and targeted breakout classes, Cloud Expo and @ThingsExpo are two of the most important technology events of the year. Since its launch over eight years ago, Cloud Expo and @ThingsExpo have presented a rock star faculty as well as...
Commerce has become both digital and global: Online sales are expected to exceed $1.6 trillion dollars by 2020. As a customer preferred way of doing business, ecommerce offers increased selection, value, and convenience. Online shopping also offers merchants increased access to custome...
These days attacks are becoming more sophisticated and more common. Mobile devices, cloud computing and the Internet of Things have increased the number of access points that must be secured. To complicate matters, CISOs are been directed to secure system without compromising the seaml...
There's an impulse to roll one's eyes and think of legacy applications as problematic, almost by definition. They're old, and they may run on hardware that's slower or more difficult to maintain. But in many instances, that's too simplistic an assessment. Would you respond the same way...
